- Home
- NDMO vs ARCT Comparison
NDMO vs ARCT Comparison
Compare NDMO & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDMO
- ARCT
- Stock Information
- Founded
- NDMO 2019
- ARCT 2013
- Country
- NDMO United States
- ARCT United States
- Employees
- NDMO N/A
- ARCT N/A
- Industry
- NDMO Trusts Except Educational Religious and Charitable
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- NDMO Finance
- ARCT Health Care
- Exchange
- NDMO Nasdaq
- ARCT Nasdaq
- Market Cap
- NDMO N/A
- ARCT 298.3M
- IPO Year
- NDMO N/A
- ARCT N/A
- Fundamental
- Price
- NDMO $10.07
- ARCT $13.19
- Analyst Decision
- NDMO
- ARCT Strong Buy
- Analyst Count
- NDMO 0
- ARCT 8
- Target Price
- NDMO N/A
- ARCT $52.33
- AVG Volume (30 Days)
- NDMO 218.6K
- ARCT 497.0K
- Earning Date
- NDMO 01-01-0001
- ARCT 08-04-2025
- Dividend Yield
- NDMO 6.75%
- ARCT N/A
- EPS Growth
- NDMO N/A
- ARCT N/A
- EPS
- NDMO N/A
- ARCT N/A
- Revenue
- NDMO N/A
- ARCT $143,680,000.00
- Revenue This Year
- NDMO N/A
- ARCT N/A
- Revenue Next Year
- NDMO N/A
- ARCT $34.79
- P/E Ratio
- NDMO N/A
- ARCT N/A
- Revenue Growth
- NDMO N/A
- ARCT 15.38
- 52 Week Low
- NDMO $8.99
- ARCT $8.04
- 52 Week High
- NDMO $11.24
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- NDMO 50.17
- ARCT 66.19
- Support Level
- NDMO $9.96
- ARCT $12.03
- Resistance Level
- NDMO $10.04
- ARCT $14.75
- Average True Range (ATR)
- NDMO 0.10
- ARCT 0.79
- MACD
- NDMO -0.02
- ARCT 0.20
- Stochastic Oscillator
- NDMO 22.50
- ARCT 89.96
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.